TORONTO, April 21, 2023 /CNW/ - CareRx Corporation ("CareRx" or the "Company") (TSX: CRRX), Canada's leading provider of pharmacy services to seniors living and other congregate care communities, today announced that David Murphy, President and Chief Executive Officer, and Puneet Khanna, Chief Operating Officer and incoming President and Chief Executive Officer, will present at the 2023 Bloom Burton & Co. Healthcare Investor Conference, taking place on April 25-26, 2023 at the Metro Toronto Convention Centre, North Building, 255 Front Street West, Toronto. Mr. Murphy and Mr. Khanna's presentation is scheduled for Tuesday, April 25, 2023 at 4:00 pm ET.

A webcast of the presentation will be available in the "Investors" section of CareRx's website at www.carerx.ca on the "Events and Presentations" page. A replay of the presentation will be available on the same page of the website following the event.

CareRx management will also be available for one-on-one meetings throughout the day. Investors interested in meeting with CareRx during the conference should contact Bloom Burton & Co.'s conference coordinator.

The Bloom Burton & Co. Healthcare Investor Conference brings together U.S., Canadian and international investors who are interested in the latest developments in the Canadian healthcare sector. Attendees will have an opportunity to obtain corporate updates from the premier Canadian publicly traded and private companies through presentations and private meetings.

About CareRx Corporation

CareRx is Canada's leading provider of pharmacy services to seniors living communities. We serve over 94,000 residents in over 1,600 seniors and other congregate care communities (long-term care homes, retirement homes, assisted living facilities, and group homes). We are a national organization with a large network of pharmacy fulfillment centres strategically located across the country. This allows us to deliver medications in a timely and cost-effective manner and quickly respond to routine changes in medication management. We use best-in-class technology that automates the preparation and verification of multi-dose compliance packaging of medication, providing the highest levels of safety and adherence for individuals with complex medication regimes. We take an active role in working with our home operator partners to promote resident health, staff education, and medication system quality and efficiency.



About Bloom Burton & Co.

Bloom Burton & Co. is a firm dedicated to accelerating returns in the healthcare sector for both investors and companies. Bloom Burton has an experienced team of medical, scientific, industry and capital markets professionals who perform a deep level of diligence, which combined with our creative and entrepreneurial approach, assists our clients in achieving the right monetization events. Bloom Burton and its affiliates provide capital raising, M&A advisory, equity research, business strategy and scientific consulting, as well as advisory on direct investing, company creation and incubation services. Bloom Burton Securities Inc. is a member of the Investment Industry Regulatory Organization of Canada (IIROC) and is also a member of the Canadian Investor Protection Fund (CIPF).

www.loderockadvisors.com

SOURCE CareRX Corporation Cision

View original content: http://www.newswire.ca/en/releases/archive/April2023/21/c2986.html